SB939, a novel potent and orally active histone deacetylase inhibitor with high tumor exposure and efficacy in mouse models of colorectal cancer. (Q43144734)
Jump to navigation
Jump to search
scientific article published on 2 March 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | SB939, a novel potent and orally active histone deacetylase inhibitor with high tumor exposure and efficacy in mouse models of colorectal cancer. |
scientific article published on 2 March 2010 |
Statements
SB939, a novel potent and orally active histone deacetylase inhibitor with high tumor exposure and efficacy in mouse models of colorectal cancer (English)
Veronica Novotny-Diermayr
Kanda Sangthongpitag
Chang Yong Hu
Xiaofeng Wu
Nina Sausgruber
Pauline Yeo
Gediminas Greicius
Sven Pettersson
Ai Leng Liang
Yung Kiang Loh
Zahid Bonday
Kee Chuan Goh
Hannes Hentze
Stefan Hart
Kantharaj Ethirajulu
Jeanette Marjorie Wood